NCT07320495Recruiting
Efficacy and Safety of the APGO Algorithm for Automated Insulin Delivery
Efficacy and Safety of the APGO Algorithm for Automated Insulin Delivery: The RENEW Study
Source: ClinicalTrials.gov · Last updated 6 Jan 2026
Brief summary (registry, in English)
The Medtrum TouchCare Nano system with the APGO algorithm is the only patch pump-based automated insulin delivery system available in the Czech Republic. However, until now, no prospective clinical study has evaluated its efficacy and safety under real-world conditions. The RENEW study is the first to address this topic.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- First submitted
- 3 Dec 2025
- Start date
- 19 Jun 2025
- Primary completion date
- 19 Jun 2027
- Lead sponsor
- Charles University, Czech Republic
- Diseases
- Type 1 diabetes
- NCT number
- NCT07320495
What you commit to
- Study type: Interventional
- Planned participants: 200
- From 19 Jun 2025 to the primary completion date, 19 Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- use of medication with effects on carbohydrate metabolism
Other
- severe noncompliance
- lactation, pregnancy, intending to become pregnant during study
Who the study is looking for
- patients with T1D
- type 1 diabetes for ≥1 years
- ≥ 18 years old
- written informed consent prior to starting study related activity
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| 3rd Department of Internal Medicine, 1st Faculty of Medicine, Charles University, Prague, Czechia Coordinator of this site? Confirm its status | Prague | Czechia | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.